KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70 JPY | 0.00% |
|
0.00% | -12.50% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Kubota Pharmaceutical Holdings Co., Ltd. is a Japan-based company mainly engaged in the operation and management of subsidiaries. Its subsidiaries are mainly engaged in discovering and developing drug candidates to treat and slow the progression of sight-threatening ophthalmic diseases. The Company operates pharmaceutical development segment. It focuses on the development of oral formulation for age-related macular degeneration (AMD), glaucoma and dry eye syndrome.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -12.50% | 25.03M | |
| +32.85% | 704B | |
| +28.59% | 577B | |
| -3.69% | 348B | |
| +18.35% | 327B | |
| +5.57% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.06% | 147B |
- Stock Market
- Equities
- 4596 Stock
- News Kubota Pharmaceutical Holdings Co., Ltd.
- Kubota Pharmaceutical Adjusts 2023 Financial Results Following Reevaluation
